{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:16:04Z","timestamp":1787991364284,"version":"build-2784847793"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"9","funder":[{"name":"Veterans Administration","award":["I01-BX001478"],"award-info":[{"award-number":["I01-BX001478"]}]},{"name":"Veterans Administration","award":["IK6-BX003782"],"award-info":[{"award-number":["IK6-BX003782"]}]},{"name":"Veterans Administration","award":["I01-RX003714"],"award-info":[{"award-number":["I01-RX003714"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AR053237"],"award-info":[{"award-number":["R01-AR053237"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-AR065971"],"award-info":[{"award-number":["T32-AR065971"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-AR083854"],"award-info":[{"award-number":["P30-AR083854"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Wnt co-receptor LRP5 plays a crucial role in skeletal physiology. Homozygous loss-of-function mutations in the Lrp5 gene produce severe osteopenia, whereas certain heterozygous point mutations produce extreme high bone mass (HBM). Different HBM-causing missense mutations are associated with variable effect magnitudes and sites of action in the skeleton. It is currently unknown whether the inclusion of 2 different HBM-causing mutations (eg, p.G171V and p.A214V), moved into the same genome, would potentiate bone mass beyond either mutation alone by manifesting their individual and divergent osteoanabolic effects. Further, a proposed unique HBM-causing mechanism of action for the G171V receptor was tested, which has poor plasma membrane localization and enriched intracellular presence. Conditional Lrp5-G171V and Lrp5-A214V were crossed to conditional mice deficient in the Wntless (Wls) gene; these mice are severely osteopenic and have impaired Wnt secretion but normal levels of intracellular (pre-released) Wnt. We tested whether the G171V mutation (which promotes intracellular localization of the receptor) would improve the skeletal phenotype induced by Wls deficiency, whereas the A214V mutation (which exhibits WT levels of plasma membrane localization) would not. The results suggest that the presence of both HBM mutations (Lrp5G171V\/A214V) does not confer additional benefits to skeletal properties beyond the homozygous presence of individual HBM-causing receptors (Lrp5G171V\/G171V or Lrp5A214V\/A214V). Further, the severe osteopenia induced by Wls loss in bone was not affected by co-expression of the G171V mutant receptor, suggesting that intracellular retention of the G171V mutant receptor is unlikely to be the mechanism of enhanced skeletal properties in G171V mice and patients. The global knock-in studies suggest that therapeutic strategies aimed at mimicking the conformational changes in the LRP5 receptor should model the A214V (alone) rather than G171V mutations for maximizing fracture resistance. Further, the conditional studies indicate that the conundrum of G171V\u2019s ability to produce an HBM phenotype, despite very low plasma membrane expression\/abundance, remains elusive.<\/jats:p>","DOI":"10.1093\/jbmr\/zjag027","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:27:01Z","timestamp":1777724821000},"page":"1012-1026","source":"Crossref","is-referenced-by-count":0,"title":["Different Lrp5-HBM mutations induce magnitude- and surface-selective effects that are not explained by receptor trafficking"],"prefix":"10.1093","volume":"41","author":[{"given":"Kyung-Eun","family":"Lim","sequence":"first","affiliation":[{"name":"Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine , Indianapolis, IN 46202 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney A","family":"Bullock","sequence":"additional","affiliation":[{"name":"Department of Biology, Eckerd College , St. Petersburg, FL 33711 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April M","family":"Hoggatt","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine , Indianapolis, IN 46202 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Horan","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine , Indianapolis, IN 46202 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Shin","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine , Indianapolis, IN 46202 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L","family":"Warman","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Boston Children's Hospital , Boston, MA 02115 ,","place":["United States"]},{"name":"Department of Genetics, Harvard Medical School , Boston, MA 02115 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G","family":"Robling","sequence":"additional","affiliation":[{"name":"Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine , Indianapolis, IN 46202 ,","place":["United States"]},{"name":"Richard L. Roudebush VA Medical Center , Indianapolis, IN 46202 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"2","key":"2026082903274111200_ref1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.4715","article-title":"High bone mass disorders: new insights from connecting the clinic and the bench","volume":"38","author":"Bergen","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026082903274111200_ref2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/1389450119666180122161503","article-title":"A review of the clinical, radiological and biochemical characteristics and genetic causes of high bone mass disorders","volume":"19","author":"Chen","year":"2018","journal-title":"Curr Drug Targets"},{"key":"2026082903274111200_ref3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.bone.2016.10.010","article-title":"Sclerostin deficiency in humans","volume":"96","author":"van Lierop","year":"2017","journal-title":"Bone."},{"issue":"9","key":"2026082903274111200_ref4","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/jbmr.161","article-title":"Sclerostin: a gem from the genome leads to bone-building antibodies","volume":"25","author":"Paszty","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2026082903274111200_ref5","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1002\/jbmr.4409","article-title":"Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the active-controlled fracture study in postmenopausal women with osteoporosis at high risk (ARCH) trial","volume":"36","author":"Brown","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026082903274111200_ref6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jbmr.2932","article-title":"Effects of romosozumab compared with teriparatide on bone density and mass at the spine and hip in postmenopausal women with low bone mass","volume":"32","author":"Genant","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2026082903274111200_ref7","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1359\/jbmr.060810","article-title":"Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity","volume":"21","author":"Ellies","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"20","key":"2026082903274111200_ref8","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"issue":"29","key":"2026082903274111200_ref9","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"280","author":"Semenov","year":"2005","journal-title":"J Biol Chem"},{"issue":"50","key":"2026082903274111200_ref10","doi-asserted-by":"crossref","first-page":"38276","DOI":"10.1074\/jbc.M609509200","article-title":"LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST","volume":"281","author":"Semenov","year":"2006","journal-title":"J Biol Chem"},{"issue":"15","key":"2026082903274111200_ref11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158320","article-title":"Novel aptamer-based small-molecule drug screening assay to identify potential sclerostin inhibitors against osteoporosis","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026082903274111200_ref12","doi-asserted-by":"crossref","first-page":"e63402","DOI":"10.7554\/eLife.63402","article-title":"Sclerostin small-molecule inhibitors promote osteogenesis by activating canonical Wnt and BMP pathways","volume":"12","author":"Sangadala","year":"2023","journal-title":"Elife"},{"key":"2026082903274111200_ref13","doi-asserted-by":"crossref","first-page":"116414","DOI":"10.1016\/j.ejmech.2024.116414","article-title":"Discovery of the small molecular inhibitors against sclerostin loop3 as potential anti-osteoporosis agents by structural based virtual screening and molecular design","volume":"271","author":"Yu","year":"2024","journal-title":"Eur J Med Chem"},{"key":"2026082903274111200_ref14","article-title":"In silico identification of sclerostin inhibitors","volume":"30","author":"Simsek","year":"2025","journal-title":"Mol Divers"},{"issue":"Pt 2","key":"2026082903274111200_ref15","doi-asserted-by":"crossref","first-page":"116587","DOI":"10.1016\/j.bcp.2024.116587","article-title":"Therapeutic targeting of Wnt antagonists by small molecules for treatment of osteoporosis","volume":"230","author":"Abhishek Shah","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"2026082903274111200_ref16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00438-023-02008-2","article-title":"Novel mutation in LRP5 gene cause rare osteosclerosis: cases studies and literature review","volume":"298","author":"Zhao","year":"2023","journal-title":"Mol Gen Genomics"},{"issue":"1","key":"2026082903274111200_ref17","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11657-023-01319-6","article-title":"LRP5 high bone mass (worth-type autosomal dominant endosteal hyperostosis): case report and historical review of the literature","volume":"18","author":"De Mattia","year":"2023","journal-title":"Arch Osteoporos"},{"issue":"6","key":"2026082903274111200_ref18","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","article-title":"Lrp5 functions in bone to regulate bone mass","volume":"17","author":"Cui","year":"2011","journal-title":"Nat Med"},{"issue":"5","key":"2026082903274111200_ref19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bone.2011.07.034","article-title":"High-bone-mass-producing mutations in the Wnt signaling pathway result in distinct skeletal phenotypes","volume":"49","author":"Niziolek","year":"2011","journal-title":"Bone"},{"issue":"10","key":"2026082903274111200_ref20","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/jbmr.2514","article-title":"High bone mass-causing mutant LRP5 receptors are resistant to endogenous inhibitors in vivo","volume":"30","author":"Niziolek","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026082903274111200_ref21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00223-008-9130-9","article-title":"The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations","volume":"82","author":"Balemans","year":"2008","journal-title":"Calcif Tissue Int"},{"issue":"12","key":"2026082903274111200_ref22","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1128\/MCB.25.12.4946-4955.2005","article-title":"Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling","volume":"25","author":"Ai","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"1-2","key":"2026082903274111200_ref23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gene.2006.12.014","article-title":"Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling","volume":"391","author":"Bhat","year":"2007","journal-title":"Gene"},{"issue":"11","key":"2026082903274111200_ref24","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1128\/MCB.24.11.4677-4684.2004","article-title":"The LRP5 high-bone-mass G171V mutation disrupts LRP5 interaction with Mesd","volume":"24","author":"Zhang","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"24","key":"2026082903274111200_ref25","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1101\/gad.10.24.3116","article-title":"The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in wingless processing","volume":"10","author":"Kadowaki","year":"1996","journal-title":"Genes Dev"},{"issue":"3","key":"2026082903274111200_ref26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.devcel.2014.03.016","article-title":"WLS retrograde transport to the endoplasmic reticulum during Wnt secretion","volume":"29","author":"Yu","year":"2014","journal-title":"Dev Cell"},{"issue":"10","key":"2026082903274111200_ref27","doi-asserted-by":"crossref","DOI":"10.1242\/dev.176073","article-title":"Mechanisms of intercellular Wnt transport","volume":"146","author":"Routledge","year":"2019","journal-title":"Development"},{"issue":"3","key":"2026082903274111200_ref28","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cell.2006.02.049","article-title":"Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells","volume":"125","author":"Banziger","year":"2006","journal-title":"Cell"},{"issue":"33","key":"2026082903274111200_ref29","doi-asserted-by":"crossref","first-page":"E2197","DOI":"10.1073\/pnas.1120407109","article-title":"Wntless functions in mature osteoblasts to regulate bone mass","volume":"109","author":"Zhong","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2026082903274111200_ref30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/dvdy.22541","article-title":"Gpr177\/mouse Wntless is essential for Wnt-mediated craniofacial and brain development","volume":"240","author":"Fu","year":"2011","journal-title":"Dev Dyn"},{"issue":"4","key":"2026082903274111200_ref31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/154405910708600404","article-title":"DMP1-targeted Cre expression in odontoblasts and osteocytes","volume":"86","author":"Lu","year":"2007","journal-title":"J Dent Res"},{"key":"2026082903274111200_ref32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bone.2018.10.007","article-title":"Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism","volume":"120","author":"Kang","year":"2019","journal-title":"Bone"},{"key":"2026082903274111200_ref33","doi-asserted-by":"crossref","first-page":"115708","DOI":"10.1016\/j.bone.2020.115708","article-title":"Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration","volume":"143","author":"Lim","year":"2021","journal-title":"Bone"},{"issue":"12","key":"2026082903274111200_ref34","doi-asserted-by":"crossref","first-page":"9785","DOI":"10.1002\/jcp.29792","article-title":"Pten deletion in Dmp1-expressing cells does not rescue the osteopenic effects of Wnt\/beta-catenin suppression","volume":"235","author":"Lim","year":"2020","journal-title":"J Cell Physiol"},{"key":"2026082903274111200_ref35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.isci.2019.09.023","article-title":"Lrp4 Mediates Bone Homeostasis and Mechanotransduction through Interaction with Sclerostin In Vivo","volume":"20","author":"Bullock","year":"2019","journal-title":"iScience"},{"issue":"7","key":"2026082903274111200_ref36","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026082903274111200_ref37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026082903274111200_ref38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/8756-3282(93)90081-K","article-title":"Basic biomechanical measurements of bone: a tutorial","volume":"14","author":"Turner","year":"1993","journal-title":"Bone"},{"issue":"1","key":"2026082903274111200_ref39","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41413-023-00278-5","article-title":"Inhibiting WNT secretion reduces high bone mass caused by Sost loss-of-function or gain-of-function mutations in Lrp5","volume":"11","author":"Diegel","year":"2023","journal-title":"Bone Res"},{"issue":"2","key":"2026082903274111200_ref40","first-page":"85","article-title":"The crucial role of Wntless in osteogenesis and odontogenesis","volume":"24","author":"Du","year":"2021","journal-title":"Chin J Dent Res"},{"key":"2026082903274111200_ref41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41413-018-0017-8","article-title":"Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy","volume":"6","author":"Madan","year":"2018","journal-title":"Bone Res"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjag027\/68267193\/zjag027.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/9\/1012\/68267193\/zjag027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/41\/9\/1012\/68267193\/zjag027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:27:53Z","timestamp":1787988473000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/41\/9\/1012\/8675788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5,11]]},"published-print":{"date-parts":[[2026,8,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjag027","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,5,11]]}}}